Vincent Serra is a highly accomplished CEO and CSO currently serving as the CEO of Arnity Therapeutics. Previously, they co-founded and held leadership roles at several biotech companies, including Wittycell and Anosys, where they focused on immunology, vaccine development, and innovative therapeutic solutions. Vincent has successfully led various research and development projects, including a notable IPO for ABIVAX, demonstrating expertise in mRNA therapeutics and collaboration with international academic and private organizations. Their academic background includes a PhD in Biology from Université Grenoble Alpes, with significant contributions to the field of immunology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices